Study: Merck hep C combo effective in kidney disease patients

Study: Merck hep C combo effective in kidney disease patients Earlier this year, the FDA granted Merck breakthrough status for its combined grazoprevir/elbasvir combination medication for treatment of hepattis C (HCV). Merck is also targeting patients with severe kidney impairment … Continue reading

Public Release: 31-Mar-2015 HIV patients experience better kidney transplant

Public Release: 31-Mar-2015 HIV patients experience better kidney transplant … Current guidelines recommend kidney transplantation as the preferred course of treatment for Hepatitis C patients, as compared to continued dialysis; however, these patients experience worse outcomes than their uninfected counterparts. … Continue reading